Skip to main content

News

German skin cancer patients join the EPIC-Skin study

 

Garching, Munich. Germany – OncoBeta® GmbH has announced University Clinic of Rostock (is particpating in the global phase IV EPIC-Skin Study (Effic…

Read more

Interview with Dr. Joe Cardaci: committee member of the international Registry

 

Dr. Joe Cardaci, committee member of the international Registry, tells us a bit about his experience with the Rhenium-SCT and this world-first…

Read more

Rhenium-SCT reached Canadian medical news in LePatient

The non-invasive, single-session treatment for non-melanoma skin cancer, Rhenium-SCT, reached Canadian medical news. Le Patient, distributed by the…

Read more

Perth skin cancer patients undergo first treatments with OncoBeta’s Rhenium-SCT as part of the EPIC-Skin study

Perth, Australia– OncoBeta® GmbH today announced Perth’s Hollywood Private Hospital in Australia is the latest medical facility to participate in the…

Read more

Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta’s Rhenium-SCT

Garching, Munich. Germany – OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV…

Read more

Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT

Garching, Munich. Germany – OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV…

Read more

EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta’s Rhenium-SCT

Garching,Munich.Germany – OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part…

Read more

EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta’s Rhenium-SCT

Garching,Munich.Germany – OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part…

Read more

EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta’s Rhenium-SCT

Garching,Munich.Germany – OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part…

Read more
OncoBeta International Registry

First patients registered into OncoBeta’s International Registry for Non-Melanoma Skin Cancer treatments

The International Registry is an observational, multicentre, non-interventional program for patients diagnosed with non-melanoma skin cancer (NMSC),…

Read more